377 related articles for article (PubMed ID: 26790671)
21. Genomic deletion size at the epsilon-sarcoglycan locus determines the clinical phenotype.
Asmus F; Hjermind LE; Dupont E; Wagenstaller J; Haberlandt E; Munz M; Strom TM; Gasser T
Brain; 2007 Oct; 130(Pt 10):2736-45. PubMed ID: 17898012
[TBL] [Abstract][Full Text] [Related]
22. Autosomal dominant myoclonus-dystonia and Tourette syndrome in a family without linkage to the SGCE gene.
Orth M; Djarmati A; Bäumer T; Winkler S; Grünewald A; Lohmann-Hedrich K; Kabakci K; Hagenah J; Klein C; Münchau A
Mov Disord; 2007 Oct; 22(14):2090-6. PubMed ID: 17702041
[TBL] [Abstract][Full Text] [Related]
23. A Case Report of Siblings with Dystonia: A Potential Link Between DYT11 Mutation and Platelet Dysfunction.
Damante MA; Ganguly R; Huntoon KM; Kraut EH; Deogaonkar M
Neurol India; 2022; 70(1):402-404. PubMed ID: 35263928
[TBL] [Abstract][Full Text] [Related]
24. Myoclonus-dystonia (DYT11) with novel SGCE mutation misdiagnosed as a primary psychiatric disorder.
Bonello M; Larner AJ; Alusi SH
J Neurol Sci; 2014 Nov; 346(1-2):356-7. PubMed ID: 25204586
[No Abstract] [Full Text] [Related]
25. A child with myoclonus-dystonia (DYT11) misdiagnosed as atypical opsoclonus myoclonus syndrome.
Drivenes B; Born AP; Ek J; Dunoe M; Uldall PV
Eur J Paediatr Neurol; 2015 Nov; 19(6):719-21. PubMed ID: 26278497
[TBL] [Abstract][Full Text] [Related]
26. SGCZ mutations are unlikely to be associated with myoclonus dystonia.
Peall KJ; Ritz K; Waite AJ; Groen JL; Morris HR; Baas F; Blake DJ; Tijssen MA
Neuroscience; 2014 Jul; 272():88-91. PubMed ID: 24792710
[TBL] [Abstract][Full Text] [Related]
27. Mutation in ε-Sarcoglycan Induces a Myoclonus-Dystonia Syndrome-Like Movement Disorder in Mice.
Li J; Liu Y; Li Q; Huang X; Zhou D; Xu H; Zhao F; Mi X; Wang R; Jia F; Xu F; Yang J; Liu D; Deng X; Zhang Y
Neurosci Bull; 2021 Mar; 37(3):311-322. PubMed ID: 33355901
[TBL] [Abstract][Full Text] [Related]
28. A novel SGCE gene mutation causing myoclonus dystonia in a family with an unusual phenotype.
Tedroff K; Rolfs A; Norling A
Acta Paediatr; 2012 Feb; 101(2):e90-2. PubMed ID: 22026499
[TBL] [Abstract][Full Text] [Related]
29. Cortical excitability in DYT-11 positive myoclonus dystonia.
; ; Roze E; Apartis E; Trocello JM;
Mov Disord; 2008 Apr; 23(5):761-4. PubMed ID: 18265016
[TBL] [Abstract][Full Text] [Related]
30. Severe myoclonus-dystonia syndrome associated with a novel epsilon-sarcoglycan gene truncating mutation.
Maréchal L; Raux G; Dumanchin C; Lefebvre G; Deslandre E; Girard C; Campion D; Parain D; Frebourg T; Hannequin D
Am J Med Genet B Neuropsychiatr Genet; 2003 May; 119B(1):114-7. PubMed ID: 12707948
[TBL] [Abstract][Full Text] [Related]
31. Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene.
Asmus F; Salih F; Hjermind LE; Ostergaard K; Munz M; Kühn AA; Dupont E; Kupsch A; Gasser T
Ann Neurol; 2005 Nov; 58(5):792-7. PubMed ID: 16240355
[TBL] [Abstract][Full Text] [Related]
32. Delayed Diagnoses of
Varga MG; Nand NP; LeDoux MS
Tremor Other Hyperkinet Mov (N Y); 2020 Jul; 10():23. PubMed ID: 32775037
[TBL] [Abstract][Full Text] [Related]
33. Clinical differentiation of genetically proven benign hereditary chorea and myoclonus-dystonia.
Asmus F; Devlin A; Munz M; Zimprich A; Gasser T; Chinnery PF
Mov Disord; 2007 Oct; 22(14):2104-9. PubMed ID: 17702043
[TBL] [Abstract][Full Text] [Related]
34. A novel mutation of the epsilon-sarcoglycan gene in a Chinese family with myoclonus-dystonia syndrome.
Chen XP; Zhang YW; Zhang SS; Chen Q; Burgunder JM; Wu SH; Yang Y; Luo ZM; Shang HF
Mov Disord; 2008 Jul; 23(10):1472-5. PubMed ID: 18581468
[TBL] [Abstract][Full Text] [Related]
35. Alteration of striatal dopaminergic neurotransmission in a mouse model of DYT11 myoclonus-dystonia.
Zhang L; Yokoi F; Parsons DS; Standaert DG; Li Y
PLoS One; 2012; 7(3):e33669. PubMed ID: 22438980
[TBL] [Abstract][Full Text] [Related]
36. Acute cerebellar knockdown of
Washburn S; Fremont R; Moreno-Escobar MC; Angueyra C; Khodakhah K
Elife; 2019 Dec; 8():. PubMed ID: 31868164
[TBL] [Abstract][Full Text] [Related]
37. ε-Sarcoglycan: Unraveling the Myoclonus-Dystonia Gene.
Cazurro-Gutiérrez A; Marcé-Grau A; Correa-Vela M; Salazar A; Vanegas MI; Macaya A; Bayés À; Pérez-Dueñas B
Mol Neurobiol; 2021 Aug; 58(8):3938-3952. PubMed ID: 33886091
[TBL] [Abstract][Full Text] [Related]
38. Novel SGCE mutation in a patient with myoclonus-dystonia syndrome - Diagnostic delay of more than 40 years.
Kübler D; Borngräber F; Lohmann K; Kühn AA
J Clin Neurosci; 2018 Apr; 50():131-132. PubMed ID: 29429788
[TBL] [Abstract][Full Text] [Related]
39. The epsilon-sarcoglycan gene in myoclonic syndromes.
Valente EM; Edwards MJ; Mir P; DiGiorgio A; Salvi S; Davis M; Russo N; Bozi M; Kim HT; Pennisi G; Quinn N; Dallapiccola B; Bhatia KP
Neurology; 2005 Feb; 64(4):737-9. PubMed ID: 15728306
[TBL] [Abstract][Full Text] [Related]
40. A Genetics Pearl for Counseling Patients with Epsilon-Sarcoglycan Myoclonus-Dystonia.
Higinbotham AS; DeBrosse SD; Kilbane CW
Tremor Other Hyperkinet Mov (N Y); 2023; 13():24. PubMed ID: 37637852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
